NIAMS P30 Centers Program (P30 - Clinical Trial Not Allowed)
Limited submission
NIH supports research centers providing shared infrastructure and expertise for skin, musculoskeletal, and rheumatic disease research, collaboration, and training; clinical trials are not allowed.
Funder: National Institutes of Health
Due Dates: February 1, 2027 (New) | March 1, 2027 (Renewal / Resubmission / Revision) | February 1, 2028 (New) | March 1, 2028 (Renewal / Resubmission / Revision) | February 1, 2029 (New) | March 1, 2029 (Renewal / Resubmission / Revision; closing date)
Funding Amounts: Up to $500,000 in direct costs annually for up to 5 years; $17 million total program funding
Summary: Supports integrated research centers providing shared infrastructure, resources, and expertise for skin, musculoskeletal, and rheumatic disease research.
Key Information: Clinical trials are not allowed, including through optional Pilot and Feasibility programs.
Description
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of NIH, administers this P30 Center Core Grants program to accelerate discovery, improve research efficiency, and translate findings into improved health outcomes. It supports integrated centers in skin biology and diseases; bone, muscle, and orthopaedic research; and rheumatic diseases.
Centers provide coordinated research infrastructure, shared resources, and methodological expertise for basic, translational, and clinical research. Resources may include laboratory technologies, computational and bioinformatics services, study design, biostatistics, data science, and clinical or translational research support. The program emphasizes multidisciplinary collaboration, rigorous data-driven research, workforce development across career stages, and training in emerging areas such as artificial intelligence and implementation research. Center components must function as an integrated whole serving a defined research community.
